The B3 S.A. - Brasil, Bolsa, Balcão News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Search entities
Discover all 2,070 supported financial entities for The B3 S.A. - Brasil, Bolsa, Balcão here.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 201,
"returned": 10,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "4f1200cb-772d-4ad3-8d61-01590ccfb76d",
"title": "New York Community Bancorp: Risk Profile And Valuation (NYSE:NYCB)",
"description": "New York Community Bancorp has emerged as a strong regional banking opportunity. Read more to see the reasons behind my bullish view on NYCB stock.",
"keywords": "",
"snippet": "Avosb\n\nThe financial strain in regional banking continues to be justified. Despite the fact that many regional banks fall below the mandatory and Basel III requ...",
"url": "https://seekingalpha.com/article/4608146-new-york-community-bancorp-risk-profile-and-valuation",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/517223530/image_517223530.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2023-05-30T11:16:51.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "SBNY34.SA",
"name": "Signature Bank",
"exchange": "BVMF",
"exchange_long": "The B3 S.A. - Brasil, Bolsa, Balcão",
"country": "br",
"type": "equity",
"industry": "Financial Services",
"match_score": 13.623289,
"sentiment_score": -0.298025,
"highlights": [
{
"highlight": "I find it extremely intriguing because the company made a shrewd selection of the assets and liabilities of the failed <em>Signature</em> <em>Bank</em> (OTC:SBNY). It does not acquire risky private equity loans or crypto-based liabilities.",
"sentiment": -0.608,
"highlighted_in": "main_text"
},
{
"highlight": "Data by YCharts\n\nFDIC takeover of <em>Signature</em> <em>Bank</em>\n\nFirst and foremost, I believe it is crucial to comprehend the nature of the \"FDIC takeover\" policy. It is crucial for a banking investor to understand how this can occur, what the investor should be aware of, and the state of the regulatory framework.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "The <em>Signature</em> <em>Bank</em>, which is also impacted by crypto-related liabilities, faces similar ongoing issues. However, the issue is more macro-related, as I discussed a few weeks ago in the bearish analysis, as short-term yields on MMF are significantly higher than those on bank savings accounts.",
"sentiment": -0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "Examine the transaction\n\nCherry-picking process\n\nIn the second half of March, Flagstar Bank, a wholly-owned subsidiary of NYCB, acquired from the FDIC, in its capacity as receiver, a substantial portion of the assets and liabilities of failed bank <em>Signature</em> <em>Bank</em>.\n\nInitially, it is prudent to analyze how the overall P&A transaction evolves.",
"sentiment": -0.3818,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "38572c43-a1c3-48ab-86e3-e17fb035d892",
"title": "AIEQ: Don't Be A Beta Tester, Avoid This Poor-Performing ETF",
"description": "The AI Powered Equity ETF has underperformed against all major market segments since its launch in 2017. See why I rate AIEQ fund a strong sell.",
"keywords": "",
"snippet": "Shutthiphong Chandaeng\n\nInvestment Thesis\n\nThe AI Powered Equity ETF (NYSEARCA:AIEQ) is the first actively-managed ETF powered by artificial intelligence, using...",
"url": "https://seekingalpha.com/article/4608145-aieq-dont-be-a-beta-tester-avoid-this-poor-performing-ai-powered-etf",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1452604857/image_1452604857.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2023-05-30T11:08:02.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "BIJR39.SA",
"name": "Ishares Core S&P Small-Cap Etf",
"exchange": "BVMF",
"exchange_long": "The B3 S.A. - Brasil, Bolsa, Balcão",
"country": "br",
"type": "equity",
"industry": "N/A",
"match_score": 37.400673,
"sentiment_score": 0.7982,
"highlights": [
{
"highlight": "in each of the following categories:\n\nLarge Value: Vanguard Value ETF (VTV) Large Blend: SPDR S&P 500 ETF (SPY) Large Growth: Invesco QQQ ETF (QQQ) Mid Value: Vanguard Mid-Cap Value ETF (VOE) Mid Blend: iShares Core S&P MidCap ETF (IJH) Mid Growth: iShares Russell Mid-Cap Growth ETF (IWP) Small Value: Vanguard Small-Cap Value ETF (VBR) Small Blend: <em>iShares</em>",
"sentiment": 0.9595,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Core</em> <em>S</em>&<em>P</em> <em>Small</em>-<em>Cap</em> <em>ETF</em> (IJR) Small Growth: Vanguard Small Cap Growth ETF (VBK)\n\nNow let's rank them by year.",
"sentiment": 0.6369,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "cf96b94a-d5a9-466f-afac-c8fec6bd8fa1",
"title": "Bristol-Myers Squibb Announces FDA Accepts for Priority Review Application for Repotrectinib for the Treatment of Patients with Locally Advanced or Metastatic ROS1-Positive NSCLC By Investing.com",
"description": "Bristol-Myers Squibb Announces FDA Accepts for Priority Review Application for Repotrectinib for the Treatment of Patients with Locally Advanced or Metastatic ROS1-Positive NSCLC",
"keywords": "",
"snippet": "Published May 30, 2023 07:00AM ET Updated May 30, 2023 07:07AM ET\n\n© Reuters. Bristol-Myers Squibb (BMY) Announces FDA Accepts for Priority Review Application ...",
"url": "https://www.investing.com/news/assorted/bristolmyers-squibb-announces-fda-accepts-for-priority-review-application-for-repotrectinib-for-the-treatment-of-patients-with-locally-advanced-or-metastatic-ros1positive-nsclc-432SI-3093737",
"image_url": "https://i-invdn-com.investing.com/news/LYNXMPEE6P1NM_L.jpg",
"language": "en",
"published_at": "2023-05-30T11:07:02.000000Z",
"source": "investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "BMYB34.SA",
"name": "Bristol-Myers Squibb Company",
"exchange": "BVMF",
"exchange_long": "The B3 S.A. - Brasil, Bolsa, Balcão",
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 85.91197,
"sentiment_score": 0.38412,
"highlights": [
{
"highlight": "<em>Bristol</em>-<em>Myers</em> <em>Squibb</em> (BMY) Announces FDA Accepts for Priority Review Application for Repotrectinib for the Treatment of Patients with Locally Advanced or Metastatic ROS1-Positive NSCLC\n\nBMY -1.15% Add to/Remove from Watchlist\n\n<em>Bristol</em> <em>Myers</em> <em>Squibb</em> (BMY) today announced that the U.S.",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "“Patients with ROS1-positive non-small cell lung cancer face a rare disease with a significant unmet medical need given the limited durability of benefit and emergence of resistance to approved therapies,” said Jonathan Cheng, M.D., senior vice president and head of oncology development, <em>Bristol</em> <em>Myers</em> <em>Squibb</em>.",
"sentiment": 0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Bristol</em> <em>Myers</em> <em>Squibb</em> thanks the patients and investigators involved with the TRIDENT-1 clinical trial.\n\nTurning Point Therapeutics is a wholly owned subsidiary of the <em>Bristol</em>-<em>Myers</em> <em>Squibb</em> <em>Company</em> (NYSE: ).",
"sentiment": 0.4404,
"highlighted_in": "main_text"
},
{
"highlight": "As of August 2022, <em>Bristol</em> <em>Myers</em> <em>Squibb</em> acquired the leading clinical stage precision oncology company and its pipeline of investigational drugs across precision oncology and advanced solid tumors, including repotrectinib.",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Bristol</em>-<em>Myers</em> <em>Squibb</em> Announces FDA Accepts for Priority Review Application for Repotrectinib for the Treatment of Patients with Locally Advanced or Metastatic ROS1-Positive NSCLC By Investing.com",
"sentiment": 0.5106,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "1b19a878-8b97-4490-9abd-e7dbc9a922cb",
"title": "Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts",
"description": "U.S. stocks closed higher on Friday. The Dow Jones ended a five-session losing streak, while the S&P 500 settled at its strongest level since Aug. 2022.",
"keywords": "",
"snippet": "U.S. stocks closed higher on Friday. The Dow Jones ended a five-session losing streak, while the S&P 500 settled at its strongest level since Aug. 2022.\n\nWall S...",
"url": "https://www.benzinga.com/news/23/05/32620790/this-analyst-with-86-accuracy-rate-sees-around-16-upside-in-nvidia-here-are-5-stock-picks-for-last-w",
"image_url": "https://cdn.benzinga.com/files/images/story/2023/05/30/nvidia-logo.jpg?width=1200&height=800&fit=crop",
"language": "en",
"published_at": "2023-05-30T11:05:48.000000Z",
"source": "benzinga.com",
"relevance_score": null,
"entities": [
{
"symbol": "BBYY34.SA",
"name": "Best Buy Co., Inc.",
"exchange": "BVMF",
"exchange_long": "The B3 S.A. - Brasil, Bolsa, Balcão",
"country": "br",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 21.121658,
"sentiment_score": 0.2804,
"highlights": [
{
"highlight": "Analyst Firm: Wells Fargo\n\nWells Fargo Ratings Accuracy: 87%\n\n87% Latest Rating: Maintained an Equal-Weight rating on <em>Best</em> <em>Buy</em> <em>Co</em>., <em>Inc</em>. BBY and cut the price target from $80 to $75 on May 26, 2023. Fadem sees around 1% upside in the company’s stock.\n\nMaintained an Equal-Weight rating on and cut the price target from $80 to $75 on May 26, 2023.",
"sentiment": -0.0516,
"highlighted_in": "main_text"
},
{
"highlight": "Recent News: <em>Best</em> <em>Buy</em> reported better-than-expected first-quarter EPS results and reaffirmed FY24 guidance.\n\nAnalyst Firm: Stifel\n\nStifel Ratings Accuracy: 87%\n\n87% Latest Rating: Reinstated a Hold rating with a price target of $28 on Clear Secure, Inc. YOU on May 26, 2023. This analyst sees around 12% upside in the stock.",
"sentiment": 0.6124,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "NVDC34.SA",
"name": "NVIDIA Corporation",
"exchange": "BVMF",
"exchange_long": "The B3 S.A. - Brasil, Bolsa, Balcão",
"country": "br",
"type": "equity",
"industry": "Technology",
"match_score": 17.552752,
"sentiment_score": 0.84615,
"highlights": [
{
"highlight": "Analyst Firm: Raymond James\n\nRaymond James Ratings Accuracy: 86%\n\n86% Latest Rating: Maintained a Strong Buy rating on <em>NVIDIA</em> <em>Corporation</em> NVDA and boosted the price target from $290 to $450 on May 25, 2023. This analyst expects around 16% gain in the company’s stock.",
"sentiment": 0.8481,
"highlighted_in": "main_text"
},
{
"highlight": "Recent News: <em>NVIDIA</em> reported better-than-expected first-quarter results and issued strong guidance..\n\nAnalyst Firm: Wells Fargo\n\nWells Fargo Ratings Accuracy: 83%\n\n83% Latest Rating: Maintained an Equal-Weight rating on Nutanix, Inc. NTNX and raised the price target from $32 to $35 on May 26, 2023. Rakers sees the stock gaining around 19%.",
"sentiment": 0.8442,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "S1PL34.SA",
"name": "Splunk Inc.",
"exchange": "BVMF",
"exchange_long": "The B3 S.A. - Brasil, Bolsa, Balcão",
"country": "br",
"type": "equity",
"industry": "Technology",
"match_score": 24.085436,
"sentiment_score": 0.1682,
"highlights": [
{
"highlight": "Analyst Firm: Piper Sandler\n\nPiper Sandler Ratings Accuracy: 83%\n\n83% Latest Rating: Maintained an Overweight rating on <em>Splunk</em> <em>Inc</em>. SPLK and raised the price target from $118 to $123 on May 25, 2023. This analyst sees around 24% growth in the stock.\n\nMaintained an Overweight rating on and raised the price target from $118 to $123 on May 25, 2023.",
"sentiment": -0.34,
"highlighted_in": "main_text"
},
{
"highlight": "Recent News: <em>Splunk</em> reported better-than-expected first-quarter financial results and issued second-quarter revenue guidance above estimates.\n\nRead More: Top 5 Health Care Stocks That Could Blast Off In May",
"sentiment": 0.6764,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "7a33ade4-d64e-4070-be5d-dc93fa716bf6",
"title": "RBI Holds Conference For Directors On Boards Of Private Sector Banks",
"description": "The Governor acknowledged the role played by the banks in supporting the economy and maintaining resilience along with improved financial performance in the face of several adverse shocks in recent times, the RBI release said, , reserve bank of india, director, private banks, Conference",
"keywords": ", reserve bank of india, director, private banks, Conference",
"snippet": "The Reserve Bank on Monday organised a conference for the directors of the boards of Private Sector Banks. The conference was held in Mumbai.\n\nRBI governor Shak...",
"url": "https://www.businessworld.in/article/RBI-Holds-Conference-For-Directors-On-Boards-Of-Private-Sector-Banks/30-05-2023-478419/",
"image_url": "https://static.businessworld.in/article/article_extra_large_image/3921460449977RBI.jpg",
"language": "en",
"published_at": "2023-05-30T11:04:38.000000Z",
"source": "businessworld.in",
"relevance_score": null,
"entities": [
{
"symbol": "SBNY34.SA",
"name": "Signature Bank",
"exchange": "BVMF",
"exchange_long": "The B3 S.A. - Brasil, Bolsa, Balcão",
"country": "br",
"type": "equity",
"industry": "Financial Services",
"match_score": 22.266367,
"sentiment_score": -0.9001,
"highlights": [
{
"highlight": "Its closure led to a contagion effect and the subsequent shutting down of other banks, <em>Signature</em> <em>Bank</em> and First Republic Bank.\n\nThe collapse of a few regional banks in the US has sent ripples across the global banking industry and posed fears of a contagion effect across economies. (ANI)",
"sentiment": -0.9001,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "4b8918f8-6f2f-4f97-abe1-7f9eb25c83ea",
"title": "Fique por dentro das 5 principais notícias do mercado desta terça-feira Por Investing.com",
"description": "Fique por dentro das 5 principais notícias do mercado desta terça-feira",
"keywords": "",
"snippet": "Publicado 30.05.2023 08:00\n\n© Reuters\n\nNVDA +2,54% Adicionar/Remover de uma Carteira LCO -1,32% Adicionar/Remover de uma Carteira ESM3 +0,59% Adicionar/Remover...",
"url": "https://br.investing.com/news/economy/fique-por-dentro-das-5-principais-noticias-do-mercado-desta-tercafeira-1118243",
"image_url": "https://i-invdn-com.investing.com/news/moved_LYNXMPEJ4G0R8_L.jpg",
"language": "pt",
"published_at": "2023-05-30T11:00:35.000000Z",
"source": "br.investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "HPQB34.SA",
"name": "HP Inc.",
"exchange": "BVMF",
"exchange_long": "The B3 S.A. - Brasil, Bolsa, Balcão",
"country": "br",
"type": "equity",
"industry": "Technology",
"match_score": 25.415041,
"sentiment_score": null,
"highlights": [
{
"highlight": "Enquanto isso, a <em>HP</em> <em>Inc</em> (NYSE: ). se prepara para divulgar seus últimos lucros, e Cathie Wood fala sobre o recente aumento das ações. No Brasil, presidente do Banco Central afirma que há espaço para continuidade do recuo dos núcleos inflacionários.\n\nCONFIRA: Calendário econômico completo do Investing.com\n\n1.",
"sentiment": 0.743,
"highlighted_in": "main_text"
},
{
"highlight": "Relatório da <em>HP</em>\n\nA <em>HP</em> <em>Inc</em> (NYSE: ) divulgará seus lucros do segundo trimestre após o fechamento das negociações de hoje nos EUA, com os investidores interessados em ver o quanto a queda pós-pandemia na demanda de PCs atingiu a fabricante de computadores pessoais e impressoras.",
"sentiment": 0.743,
"highlighted_in": "main_text"
},
{
"highlight": "No início deste ano, a <em>HP</em> previu que as vendas de sua divisão de sistemas pessoais, que inclui computadores e notebooks, cairão \"sequencialmente em um dígito alto\" no segundo trimestre. Entretanto, espera-se que a receita da unidade melhore na segunda metade do ano, à medida que os níveis elevados de estoque se normalizem.\n\n5.",
"sentiment": 0.743,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "G1AR34.SA",
"name": "Gartner, Inc.",
"exchange": "BVMF",
"exchange_long": "The B3 S.A. - Brasil, Bolsa, Balcão",
"country": "br",
"type": "equity",
"industry": "Technology",
"match_score": 11.841927,
"sentiment_score": null,
"highlights": [
{
"highlight": "As remessas mundiais de PCs totalizaram 55,2 milhões no primeiro trimestre de 2023, representando uma queda de 30% em relação ao ano anterior, de acordo com os resultados preliminares de um estudo da <em>Gartner</em> divulgado no mês passado.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "c1c5b3f6-e8c8-4268-836c-0a1ecd952a03",
"title": "Global Amblyopia Market Size To Grow USD 7.9 Billion By 2032 | CAGR of 5.5%",
"description": "The Global Amblyopia Market Size was valued at USD 4.6 Billion in 2022 and the Worldwide Amblyopia Market size is expected to reach USD 7.9 Billion by...",
"keywords": "SPHERICAL INSIGHTS LLP, Amblyopia, Amblyopia Market, Amblyopia Market Share, Amblyopia Market Size, Amblyopia Market Price, Demand, SI",
"snippet": "New York, United States , May 30, 2023 (GLOBE NEWSWIRE) -- The Global Amblyopia Market Size is to grow from USD 4.6 billion in 2022 to USD 7.9 billion by 2032, ...",
"url": "https://www.globenewswire.com/news-release/2023/05/30/2678209/0/en/Global-Amblyopia-Market-Size-To-Grow-USD-7-9-Billion-By-2032-CAGR-of-5-5.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/b27a94e8-407e-46ae-a5c2-47bb2a1c8a2e",
"language": "en",
"published_at": "2023-05-30T11:00:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "ABBV34.SA",
"name": "AbbVie Inc.",
"exchange": "BVMF",
"exchange_long": "The B3 S.A. - Brasil, Bolsa, Balcão",
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 10.209828,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "Major vendors in Global Amblyopia Market include Novartis AG, <em>Abbvie</em>, <em>Inc</em>, Bausch Health Companies Inc, Integra LifeSciences, Alcon, Astellas Pharma Inc., Takeda Pharmaceutical Company Limited, Vertex Pharmaceuticals Incorporated, F.",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "TAKP34.SA",
"name": "Takeda Pharmaceutical Company Limited",
"exchange": "BVMF",
"exchange_long": "The B3 S.A. - Brasil, Bolsa, Balcão",
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 18.763391,
"sentiment_score": 0.25,
"highlights": [
{
"highlight": "., <em>Takeda</em> <em>Pharmaceutical</em> <em>Company</em> <em>Limited</em>, Vertex Pharmaceuticals Incorporated, F. Hoffmann-La Roche Ltd, Fresnel Prism and Lens Co, Lancastle International Ltd, Good-Lite, RevitalVision, Vivid Vision, Inc, & Others.",
"sentiment": 0.25,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "N1VS34.SA",
"name": "Novartis AG",
"exchange": "BVMF",
"exchange_long": "The B3 S.A. - Brasil, Bolsa, Balcão",
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 10.488346,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "Major vendors in Global Amblyopia Market include <em>Novartis</em> <em>AG</em>, Abbvie, Inc, Bausch Health Companies Inc, Integra LifeSciences, Alcon, Astellas Pharma Inc., Takeda Pharmaceutical Company Limited, Vertex Pharmaceuticals Incorporated, F.",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "VRTX34.SA",
"name": "Vertex Pharmaceuticals Incorporated",
"exchange": "BVMF",
"exchange_long": "The B3 S.A. - Brasil, Bolsa, Balcão",
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 19.947891,
"sentiment_score": 0.0258,
"highlights": [
{
"highlight": "., Takeda Pharmaceutical Company Limited, <em>Vertex</em> <em>Pharmaceuticals</em> <em>Incorporated</em>, F. Hoffmann-La Roche Ltd, Fresnel Prism and Lens Co, Lancastle International Ltd, Good-Lite, RevitalVision, Vivid Vision, Inc, & Others.",
"sentiment": 0.0258,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "3f7c84d4-1dac-4540-a153-36cd8420401e",
"title": "In-Depth Research on VR in Healthcare Market Size | USD 25.22 Billion by 2030",
"description": "As per the report by Fortune Business Insights, the global Virtual Reality in Healthcare Market size is projected to reach USD 25.22 Billion by 2030, at a...",
"keywords": "Fortune Business Insights, VR in Healthcare Market, VR in Healthcare",
"snippet": "Pune, India, May 30, 2023 (GLOBE NEWSWIRE) -- According to Fortune Business Insights, global virtual reality in healthcare market was valued at USD 2.33 billion...",
"url": "https://www.globenewswire.com/news-release/2023/05/30/2678208/0/en/In-Depth-Research-on-VR-in-Healthcare-Market-Size-USD-25-22-Billion-by-2030.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/05408ba1-26b1-4fdd-8f48-1af4df373348",
"language": "en",
"published_at": "2023-05-30T11:00:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "FBOK34.SA",
"name": "Facebook, Inc.",
"exchange": "BVMF",
"exchange_long": "The B3 S.A. - Brasil, Bolsa, Balcão",
"country": "br",
"type": "equity",
"industry": "Communication Services",
"match_score": 8.525677,
"sentiment_score": 0,
"highlights": [
{
"highlight": ".), Oculus Rift (<em>Facebook</em> <em>Inc</em>.) (U.S.), Medical Realities Ltd. (U.K.), XRHealth USA Inc.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "1b72bdca-2dfe-445b-ae13-4403c775c9c6",
"title": "In-Depth Research on Integrated Circuit Market Size | USD 1,136.98 Billion by 2028",
"description": "As per the report by Fortune Business Insights, the global integrated circuit market size is projected to reach USD 1136.98 Billion by 2028, at a CAGR of...",
"keywords": "Fortune Business Insights, Integrated Circuit, Integrated Circuit Market",
"snippet": "Pune, India, May 30, 2023 (GLOBE NEWSWIRE) -- According to Fortune Business Insights, global integrated circuit market size was valued at USD 437.71 billion in ...",
"url": "https://www.globenewswire.com/news-release/2023/05/30/2678169/0/en/In-Depth-Research-on-Integrated-Circuit-Market-Size-USD-1-136-98-Billion-by-2028.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/05408ba1-26b1-4fdd-8f48-1af4df373348",
"language": "en",
"published_at": "2023-05-30T10:53:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "MUTC34.SA",
"name": "Micron Technology, Inc.",
"exchange": "BVMF",
"exchange_long": "The B3 S.A. - Brasil, Bolsa, Balcão",
"country": "br",
"type": "equity",
"industry": "Technology",
"match_score": 19.514803,
"sentiment_score": 0,
"highlights": [
{
"highlight": ".), <em>Micron</em> <em>Technology</em>, <em>Inc</em>. (Idaho, U.S.), Avago Technologies (Broadcom) (California, U.S.)”",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "3a3a1fe1-a106-401e-8cdb-b74b131833a4",
"title": "Target: Making Sense Of The Boycott Calls And Q1 Earnings (NYSE:TGT)",
"description": "Target's Q1 was mixed and increase in traffic is completely offset by the fact that consumers pay less on average. Read why I have a buy rating on TGT stock.",
"keywords": "",
"snippet": "Introduction\n\nSundry Photography\n\nOne of my regular readers recently asked me to look at the growth prospects of Target Corporation (NYSE:TGT), and I gladly agr...",
"url": "https://seekingalpha.com/article/4608140-target-making-sense-boycott-calls-q1-earnings",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1030492302/image_1030492302.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2023-05-30T10:51:40.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "TGTB34.SA",
"name": "Target Corporation",
"exchange": "BVMF",
"exchange_long": "The B3 S.A. - Brasil, Bolsa, Balcão",
"country": "br",
"type": "equity",
"industry": "Consumer Defensive",
"match_score": 27.3867,
"sentiment_score": 0.204309,
"highlights": [
{
"highlight": "Introduction\n\nSundry Photography\n\nOne of my regular readers recently asked me to look at the growth prospects of <em>Target</em> <em>Corporation</em> (NYSE:TGT), and I gladly agreed because this company seemed interesting enough to investigate.",
"sentiment": 0.875,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Target</em> Corporation's Q1 FY2023 results showed a 4.8% decrease in EPS to $2.05, beating estimates though by 14.7%, according to Seeking Alpha's data. Comparable sales remained flat in Q1, below the consensus estimate, with in-store sales rising 0.7% and digital sales declining 3.4%.",
"sentiment": -0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Target</em> highlighted its focus on convenience and customer response, but customers expressed concerns about inflation.\n\nThe company's Q2 outlook fell below expectations. <em>Target</em> expects a decline in Q2 comparable sales in the low single digits, with EPS projected to be between $1.30 and $1.70, lower than previous estimates.",
"sentiment": -0.6652,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Target</em> experienced an increase in gross margin due to lower freight costs, price increases, and lower clearance markdown rates. However, theft resulted in a projected $500 million profit drag from shrinkage.",
"sentiment": -0.4939,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Target</em> aims for a five-year EPS growth rate of 7%, with anticipated sales growth of around 3% and an operating margin of 5.7% by FY2025, according to his calculations. The company's ability to navigate inflation and drive sales growth will be crucial moving forward, he notes.",
"sentiment": 0.8442,
"highlighted_in": "main_text"
},
{
"highlight": "TGT's 10-Q, author's notes\n\nIn Q1 FY2023, <em>Target</em> <em>Corporation</em> did not engage in any share repurchases. As of that quarter, the remaining dollar value of shares that can still be purchased under the repurchase program amounted to $9.7 billion.",
"sentiment": 0.6586,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Target</em> faced controversy and backlash after launching its \"PRIDE\" collection, described as LGBTQ+-friendly clothing for kids. The backlash led to calls for a boycott on social media, causing the retailer to experience a significant decline in market value [~$10 billion in 10 trading sessions], based on NYP's report.",
"sentiment": 0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "In the case of <em>Target</em>, it's remarkable how quickly management reacted to the emerging backlash and threats - the retailer decided to make adjustments to its plans and remove certain items from its store.",
"sentiment": 0.4404,
"highlighted_in": "main_text"
},
{
"highlight": "One way to gauge the extent is to look at a map of states where <em>Target</em> has a strong presence and compare it to states that have enacted bans on medical care for transgender youth [a pretty reliable sign of LGBTQ+ intolerance, in my opinion].",
"sentiment": 0.8658,
"highlighted_in": "main_text"
},
{
"highlight": "Using a risk-free rate of 3.8% derived from 10-year treasuries, and assuming the market's risk premium of about 5%, the resulting WACC for <em>Target</em> should be 7.69%, which I believe is relatively optimistic.",
"sentiment": 0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Target</em>: Making Sense Of The Boycott Calls And Q1 Earnings (NYSE:TGT)",
"sentiment": -0.3182,
"highlighted_in": "title"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "BVMF",
"total_documents": 275,
"sentiment_avg": 0.18758983443652796
}
]
}
Other details
Country
- br
- 2,070